Empower Clinics Inc. (EPWCF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 | 2.96 Million USD | -41.18% |
| 2021 | 5.03 Million USD | -45.43% |
| 2020 | 9.23 Million USD | 493.31% |
| 2019 | 1.55 Million USD | 202.79% |
| 2018 | 513.79 Thousand USD | 3569.94% |
| 2017 | 14 Thousand USD | -73.08% |
| 2016 | 52 Thousand USD | -68.1% |
| 2015 | 163 Thousand USD | -60.15% |
| 2014 | 409 Thousand USD | -87.32% |
| 2013 | 3.22 Million USD | -78.97% |
| 2012 | 15.34 Million USD | 49.7% |
| 2011 | 10.24 Million USD | 473.45% |
| 2010 | 1.78 Million USD | -35.17% |
| 2009 | 2.75 Million USD | 149.56% |
| 2008 | 1.1 Million USD | -16.22% |
| 2007 | 1.31 Million USD | -2.23% |
| 2006 | 1.34 Million USD | 8455.09% |
| 2005 | 15.76 Thousand USD | -55.03% |
| 2004 | 35.04 Thousand USD | -64.93% |
| 2003 | 99.94 Thousand USD | -78.95% |
| 2002 | 474.78 Thousand USD | -16.9% |
| 2001 | 571.32 Thousand USD | -58.95% |
| 2000 | 1.39 Million USD | 9.27% |
| 1999 | 1.27 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 Q1 | 6.02 Million USD | 19.67% |
| 2022 Q2 | 4.34 Million USD | -27.85% |
| 2022 Q4 | 2.96 Million USD | -14.16% |
| 2022 FY | 2.96 Million USD | -41.2% |
| 2022 Q3 | 3.45 Million USD | -20.68% |
| 2021 Q1 | 11.13 Million USD | 20.68% |
| 2021 FY | 5.03 Million USD | -45.43% |
| 2021 Q2 | 10.77 Million USD | -3.29% |
| 2021 Q3 | 12.12 Million USD | 12.52% |
| 2021 Q4 | 5.03 Million USD | -58.44% |
| 2020 Q1 | 1.39 Million USD | -10.51% |
| 2020 Q3 | 1.44 Million USD | -19.62% |
| 2020 Q2 | 1.8 Million USD | 29.29% |
| 2020 Q4 | 9.23 Million USD | 537.93% |
| 2020 FY | 9.23 Million USD | 493.31% |
| 2019 FY | 1.55 Million USD | 202.79% |
| 2019 Q4 | 1.55 Million USD | -68.53% |
| 2019 Q1 | 2.41 Million USD | 370.44% |
| 2019 Q2 | 5.75 Million USD | 138.29% |
| 2019 Q3 | 4.94 Million USD | -14.18% |
| 2018 Q2 | 1.03 Million USD | 6822.3% |
| 2018 Q3 | 1.54 Million USD | 48.85% |
| 2018 Q4 | 513.79 Thousand USD | -66.76% |
| 2018 FY | 513.79 Thousand USD | 3569.94% |
| 2018 Q1 | 15 Thousand USD | 7.14% |
| 2017 FY | 14 Thousand USD | -73.08% |
| 2017 Q3 | 13 Thousand USD | -27.78% |
| 2017 Q2 | 18 Thousand USD | -37.93% |
| 2017 Q1 | 29 Thousand USD | -44.23% |
| 2017 Q4 | 14 Thousand USD | 7.69% |
| 2016 FY | 52 Thousand USD | -68.1% |
| 2016 Q3 | 135 Thousand USD | -6.9% |
| 2016 Q1 | 93 Thousand USD | -42.94% |
| 2016 Q2 | 145 Thousand USD | 55.91% |
| 2016 Q4 | 52 Thousand USD | -61.48% |
| 2015 FY | 163 Thousand USD | -60.15% |
| 2015 Q1 | 337 Thousand USD | -17.6% |
| 2015 Q3 | 211 Thousand USD | -16.6% |
| 2015 Q4 | 163 Thousand USD | -22.75% |
| 2015 Q2 | 253 Thousand USD | -24.93% |
| 2014 Q4 | 409 Thousand USD | -23.98% |
| 2014 Q1 | 1.23 Million USD | -61.81% |
| 2014 Q2 | 550 Thousand USD | -55.36% |
| 2014 Q3 | 538 Thousand USD | -2.18% |
| 2014 FY | 409 Thousand USD | -87.32% |
| 2013 Q4 | 3.22 Million USD | -32.58% |
| 2013 FY | 3.22 Million USD | -78.97% |
| 2013 Q2 | 9.67 Million USD | -9.19% |
| 2013 Q1 | 10.65 Million USD | -30.57% |
| 2013 Q3 | 4.78 Million USD | -50.52% |
| 2012 Q4 | 15.34 Million USD | -32.0% |
| 2012 Q3 | 22.56 Million USD | 58.66% |
| 2012 Q2 | 14.21 Million USD | 21.62% |
| 2012 Q1 | 11.69 Million USD | 14.09% |
| 2012 FY | 15.34 Million USD | 49.7% |
| 2011 Q3 | 11.34 Million USD | -32.68% |
| 2011 FY | 10.24 Million USD | 473.45% |
| 2011 Q1 | 16.45 Million USD | -10.37% |
| 2011 Q4 | 10.24 Million USD | -9.7% |
| 2011 Q2 | 16.85 Million USD | 2.41% |
| 2010 Q2 | 3.76 Million USD | 85.13% |
| 2010 FY | 1.78 Million USD | -35.17% |
| 2010 Q4 | 18.36 Million USD | 927.66% |
| 2010 Q3 | 1.78 Million USD | -52.56% |
| 2010 Q1 | 2.03 Million USD | -16.1% |
| 2009 Q4 | 2.42 Million USD | -12.01% |
| 2009 FY | 2.75 Million USD | 149.56% |
| 2009 Q1 | 973.2 Thousand USD | -7.29% |
| 2009 Q2 | 946.12 Thousand USD | -2.78% |
| 2009 Q3 | 2.75 Million USD | 191.32% |
| 2008 FY | 1.1 Million USD | -16.22% |
| 2008 Q4 | 1.04 Million USD | -4.96% |
| 2008 Q1 | 1.21 Million USD | -6.68% |
| 2008 Q2 | 1.16 Million USD | -4.16% |
| 2008 Q3 | 1.1 Million USD | -5.05% |
| 2007 Q3 | 1.31 Million USD | -0.74% |
| 2007 Q4 | 1.3 Million USD | -1.34% |
| 2007 Q2 | 1.32 Million USD | -0.16% |
| 2007 Q1 | 1.33 Million USD | -1.13% |
| 2007 FY | 1.31 Million USD | -2.23% |
| 2006 FY | 1.34 Million USD | 8455.09% |
| 2006 Q4 | 1.34 Million USD | -0.21% |
| 2006 Q3 | 1.34 Million USD | 0.32% |
| 2006 Q2 | 1.34 Million USD | -2.39% |
| 2006 Q1 | 1.37 Million USD | 9801.45% |
| 2005 Q1 | 19.9 Thousand USD | -33.2% |
| 2005 Q2 | 16.65 Thousand USD | -16.36% |
| 2005 Q4 | 13.9 Thousand USD | -11.77% |
| 2005 Q3 | 15.76 Thousand USD | -5.36% |
| 2005 FY | 15.76 Thousand USD | -55.03% |
| 2004 FY | 35.04 Thousand USD | -64.93% |
| 2004 Q3 | 35.04 Thousand USD | -51.14% |
| 2004 Q1 | 78.16 Thousand USD | -17.98% |
| 2004 Q2 | 71.72 Thousand USD | -8.24% |
| 2004 Q4 | 29.8 Thousand USD | -14.96% |
| 2003 Q3 | 99.94 Thousand USD | -8.14% |
| 2003 FY | 99.94 Thousand USD | -78.95% |
| 2003 Q4 | 95.3 Thousand USD | -4.64% |
| 2003 Q2 | 108.79 Thousand USD | -8.14% |
| 2003 Q1 | 118.44 Thousand USD | -73.88% |
| 2002 FY | 474.78 Thousand USD | -16.9% |
| 2002 Q1 | 511.04 Thousand USD | -8.07% |
| 2002 Q2 | 488.93 Thousand USD | -4.33% |
| 2002 Q4 | 453.48 Thousand USD | -4.49% |
| 2002 Q3 | 474.78 Thousand USD | -2.89% |
| 2001 Q4 | 555.88 Thousand USD | -2.7% |
| 2001 Q1 | 638.48 Thousand USD | -5.76% |
| 2001 Q2 | 626.49 Thousand USD | -1.88% |
| 2001 Q3 | 571.32 Thousand USD | -8.81% |
| 2001 FY | 571.32 Thousand USD | -58.95% |
| 2000 Q3 | 1.39 Million USD | -1.85% |
| 2000 Q4 | 677.54 Thousand USD | -51.32% |
| 2000 FY | 1.39 Million USD | 9.27% |
| 2000 Q2 | 1.41 Million USD | 0.0% |
| 1999 Q3 | 1.27 Million USD | 0.0% |
| 1999 FY | 1.27 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| The Amacore Group, Inc. | 12.04 Million USD | 75.402% |
| Arem Pacific Corporation | 259.81 Thousand USD | -1040.474% |
| Assisted 4 Living, Inc. | 264.81 Thousand USD | -1018.944% |
| BioCorRx Inc. | 388.88 Thousand USD | -661.938% |
| Bionik Laboratories Corp. | 3.36 Million USD | 11.869% |
| Banyan Corp. | 4.5 Million USD | 34.197% |
| Clearday, Inc. | 33.75 Million USD | 91.221% |
| Dental Patient Care America, Inc. | 2.24 Million USD | -32.058% |
| Quantum Medical Transport, Inc. | 1298.56 USD | -228081.678% |
| First Choice Healthcare Solutions, Inc. | 3.12 Million USD | 5.128% |
| Selectis Health, Inc. | 40.67 Million USD | 92.715% |
| Ethema Health Corporation | 11.51 Million USD | 74.277% |
| HealthLynked Corp. | 4.28 Million USD | 30.772% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 93.12 Million USD | 96.818% |
| JRSIS Health Care Corporation | 2.14 Million USD | -38.169% |
| Comjoyful International Company | 1.21 Million USD | -143.277% |
| Medical Facilities Corporation | 353.06 Million USD | 99.161% |
| MedSmart Group Inc. | 751.69 Thousand USD | -294.184% |
| North America Frac Sand, Inc. | 356.16 Thousand USD | -731.932% |
| Nova Leap Health Corp. | 20.89 Million USD | 85.82% |
| Nexteligent Holdings, Inc. | 446.95 Thousand USD | -562.947% |
| PAO Group, Inc. | 575.00 USD | -515217.565% |
| Primemd Inc. | 15.32 Million USD | 80.664% |
| Raffles Medical Group Ltd | 1.15 Billion USD | 99.744% |
| Ryman Healthcare Limited | 7.82 Billion USD | 99.962% |
| Stem Cell Authority, Ltd. | 15.00 USD | -19753740.0% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 7.22 Million USD | 58.985% |
| Mycotopia Therapies, Inc. | 2.21 Million USD | -33.507% |
| U.S. NeuroSurgical Holdings, Inc. | 1.32 Million USD | -124.306% |
| Veltex Corporation | 1.8 Million USD | -64.33% |
| World Financial Holding Group | 292.00 USD | -1014652.055% |
| Xcelerate Inc. | 1.91 Million USD | -54.41% |